鼻咽癌患者顺铂联合氟尿嘧啶两种不同诱导化疗方案的急性毒性比较
2015年7月至2016年12月前瞻性随机纳入110例III-IV期鼻咽癌患者,比较三周方案顺铂+5-氟尿嘧啶(PF)3周期与周方案P-F 10次诱导化疗后同一IMRT的急性毒性。周方案组3/4级中性粒细胞减少、厌食、黏膜炎和低钠血症均低于三周方案组,诱导化疗中断和急诊就诊更少,完全缓解率更高、复发率更低。
要点
- 周方案P-F较三周PF显著降低3/4级中性粒细胞减少(12.7% vs 40.0%,P=0.0012)等急性毒性。
- 周方案组诱导化疗中断率1.8% vs 16.4%(P=0.0203),急诊就诊率0% vs 12.7%(P=0.0128)。
- 中位随访67个月,周方案组完全缓解率83.6% vs 61.8%(P=0.0152),复发率16.4% vs 33.3%(P=0.0402)。
核心结论
- 周方案诱导化疗减少急性毒性,且未损害肿瘤缓解和生存。
研究设计与样本
- 2015年7月至2016年12月前瞻性随机研究,纳入110例III-IV期鼻咽癌患者,随机接受三周PF方案3周期或周方案P-F 10次,随后均接受同一IMRT。
主要发现
- 周方案P-F组 vs 三周PF组:3/4级中性粒细胞减少12.7% vs 40.0%(P=0.0012),厌食0% vs 14.6%(P=0.0059),黏膜炎0% vs 14.6%(P=0.0059),低钠血症0% vs 16.4%(P=0.0027)。
- 周方案P-F组 vs 三周PF组:诱导化疗中断1.8% vs 16.4%(P=0.0203),急诊就诊0% vs 12.7%(P=0.0128),额外住院0% vs 9.1%(P=0.0568)。
- IMRT期间两组急性毒性相似。
- 中位随访67个月,周方案P-F组 vs 三周PF组:完全缓解率83.6% vs 61.8%(P=0.0152),复发率16.4% vs 33.3%(P=0.0402)。
- Kaplan-Meier分析显示周方案P-F组在局部区域无失败生存(P=0.0892)、无远处转移失败生存(P=0.0775)和无进展生存(P=0.0709)方面有更好趋势。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the acute toxicity of two different induction chemotherapy (IndCT) regimen followed by the same IMRT in patients with advanced nasopharyngeal carcinoma (NPC). MATERIALS AND METHODS: From July 2015 to December 2016, 110 NPC patients with stage III-IV diseases were prospectively randomized to receive either a conventional triweekly cisplatin + 5-fluorouracil (PF) for 3 cycles or weekly P-F for 10 doses, followed by the same IMRT to both arms. The primary endpoints of this study were grade 3/4 and any grade acute toxicities during IndCT period. The secondary endpoints included tumor response and various survivals. RESULTS: Baseline patient characteristics were comparable in both groups. Patients who received weekly P-F experienced significant reduction of grade 3/4 acute toxicities, including neutropenia (12.7% vs. 40.0%, P = 0.0012), anorexia (0% vs. 14.6%, P = 0.0059), mucositis (0% vs. 14.6%, P = 0.0059), and hyponatremia (0% vs. 16.4%, P = 0.0027), compared with the triweekly PF group, resulting in fewer IndCT interruptions (1.8% vs. 16.4%, P = 0.0203), emergency room visits (0% vs. 12.7%, P = 0.0128), and additional hospitalizations (0% vs. 9.1%, P = 0.0568). The acute toxicities during IMRT period were similar. Weekly P-F arm had higher complete response rates (83.6% vs. 61.8%, P = 0.0152) and lower relapse rates (16.4% vs. 33.3%, P = 0.0402) after a median follow-up of 67 months. Kaplan-Meier survival analyses revealed a better trend of locoregional failure-free (P = 0.0892), distant metastasis failure-free (P = 0.0775), and progression-free (P = 0.0709) survivals, favoring the weekly P-F arm. CONCLUSION: IndCT of weekly schedule does reduce acute toxicities without compromised tumor response and survivals.
引用
- Zong JF, Lin PJ, Tsou HH, et al. Comparison the acute toxicity of two different induction chemotherapy schedules with cisplatin and fluorouracil in nasopharyngeal carcinoma patients. Radiother Oncol. 2023. PMID: 37169301. doi:10.1016/j.radonc.2023.109699
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。